首页> 外文期刊>Bioscience, Biotechnology, and Biochemistry >Use of Gifu Anaerobic Medium for culturing 32 dominant species of human gut microbes and its evaluation based on short-chain fatty acids fermentation profiles
【24h】

Use of Gifu Anaerobic Medium for culturing 32 dominant species of human gut microbes and its evaluation based on short-chain fatty acids fermentation profiles

机译:使用Gifu厌氧培养基培养32种人体肠道微生物的32种显性种类及其基于短链脂肪酸发酵型材的评价

获取原文
获取原文并翻译 | 示例
           

摘要

Recently, a "human gut microbial gene catalogue," which ranks the dominance of microbe genus/species in human fecal samples, was published. Most of the bacteria ranked in the catalog are currently publicly available; however, the growth media recommended by the distributors vary among species, hampering physiological comparisons among the bacteria. To address this problem, we evaluated Gifu anaerobic medium (GAM) as a standard medium. Forty-four publicly available species of the top 56 species listed in the "human gut microbial gene catalogue" were cultured in GAM, and out of these, 32 (72%) were successfully cultured. Short-chain fatty acids from the bacterial culture supernatants were then quantified, and bacterial metabolic pathways were predicted based on in silico genomic sequence analysis. Our system provides a useful platform for assessing growth properties and analyzing metabolites of dominant human gut bacteria grown in GAM and supplemented with compounds of interest.
机译:最近,发表了一种“人体肠道微生物基因目录”,其排名在人类粪便样本中微生物属/种类的优势。 目录中排名的大部分细菌目前是公开可用的; 然而,经销商推荐的生长介质在物种之间变化,妨碍细菌之间的生理比较。 为了解决这个问题,我们评估了Gifu Anaerobic Medium(Gam)作为标准媒体。 “人体肠道微生物基因目录”中列出的前56种的45种公开物种在Gam中培养,其中32(72%)成功培养。 然后量化来自细菌培养上清液的短链脂肪酸,并且基于硅基因组序列分析预测细菌代谢途径。 我们的系统提供了一种有用的平台,用于评估在GAM中生长的显性人体肠道细菌的增长性能和分析源自感兴趣的化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号